» Articles » PMID: 37928881

The Effects of E'Jiao on Body Composition, Bone Marrow Adiposity and Skeletal Redox Status in Ovariectomised Rats

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2023 Nov 6
PMID 37928881
Authors
Affiliations
Soon will be listed here.
Abstract

Menopause is accompanied by increased oxidative stress, partly contributing to weight gain and bone marrow adiposity. Traditional Chinese medication, E'Jiao, has been demonstrated to reduce excessive bone remodelling during oestrogen deprivation, but its effects on body composition and bone marrow adiposity during menopause remain elusive. To determine the effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised (OVX) rats. Seven groups of three-month-old female Sprague Dawley rats were established (n=6/group): baseline, sham, OVX control, OVX-treated with low, medium or high-dose E'Jiao (0.26, 0.53, 1.06 g/kg, p.o.) or calcium carbonate (1% in tap water, ). The supplementation was terminated after 8 weeks. Whole-body composition analysis was performed monthly using dual-energy X-ray absorptiometry. Analysis of bone-marrow adipocyte numbers and skeletal antioxidant activities were performed on the femur. Increased total mass, lean mass, and bone marrow adipocyte number were observed in the OVX control versus the sham group. Low-dose E'Jiao supplementation counteracted these changes. Besides, E'Jiao at all doses increased skeletal catalase and superoxide dismutase activities but lowered glutathione levels in the OVX rats. Skeletal malondialdehyde level was not affected by ovariectomy but was lowered with E'Jiao supplementation. However, peroxisome proliferator-activated receptor gamma protein expression was not affected by ovariectomy or any treatment. E'Jiao, especially at the low dose, prevented body composition changes and bone marrow adiposity due to ovariectomy. These changes could be mediated by the antioxidant actions of E'Jiao. It has the potential to be used among postmenopausal women to avoid adiposity.

References
1.
Zhang Y, Ye T, Hong Z, Gong S, Zhou X, Liu H . Pharmacological and transcriptome profiling analyses of Fufang E'jiao Jiang during chemotherapy-induced myelosuppression in mice. J Ethnopharmacol. 2019; 238:111869. DOI: 10.1016/j.jep.2019.111869. View

2.
Greendale G, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K . Changes in body composition and weight during the menopause transition. JCI Insight. 2019; 4(5). PMC: 6483504. DOI: 10.1172/jci.insight.124865. View

3.
Sharp J, Copps J, Liu Q, Ryner L, Sebastian R, Zeng G . Analysis of ovariectomy and estrogen effects on body composition in rats by X-ray and magnetic resonance imaging techniques. J Bone Miner Res. 2000; 15(1):138-46. DOI: 10.1359/jbmr.2000.15.1.138. View

4.
Witte M, Resuehr D, Chandler A, Mehle A, Overton J . Female mice and rats exhibit species-specific metabolic and behavioral responses to ovariectomy. Gen Comp Endocrinol. 2010; 166(3):520-8. PMC: 2856744. DOI: 10.1016/j.ygcen.2010.01.006. View

5.
Bonaccorsi G, Piva I, Greco P, Cervellati C . Oxidative stress as a possible pathogenic cofactor of post-menopausal osteoporosis: Existing evidence in support of the axis oestrogen deficiency-redox imbalance-bone loss. Indian J Med Res. 2018; 147(4):341-351. PMC: 6057254. DOI: 10.4103/ijmr.IJMR_524_18. View